Poseida Therapeutics

$8.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.35 (-3.93%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell PSTX and other stocks, options, and ETFs commission-free!

About PSTX

Poseida Therapeutics, Inc. Common Stock, also called Poseida Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors.

CEO
Eric M. Ostertag
Employees
206
Headquarters
San Diego, California
Founded
2014
Market Cap
531.62M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
176.78K
High Today
$8.93
Low Today
$8.38
Open Price
$8.93
Volume
112.54K
52 Week High
$17.62
52 Week Low
$7.63

PSTX Earnings

-$2.28
-$1.52
-$0.76
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

ACU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure